Provided by Tiger Trade Technology Pte. Ltd.

Cyclerion Therapeutics, Inc.

3.89
-0.1800-4.42%
Post-market: 4.050.1600+4.11%19:57 EDT
Volume:65.75K
Turnover:263.10K
Market Cap:18.21M
PE:-2.24
High:4.29
Open:4.07
Low:3.78
Close:4.07
52wk High:8.48
52wk Low:1.03
Shares:4.68M
Float Shares:3.58M
Volume Ratio:2.12
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7328
EPS(LYR):-1.1100
ROE:-98.22%
ROA:-52.33%
PB:3.58
PE(LYR):-3.50

Loading ...

Cyclerion FY26 Q2 Net Loss Widens to $1.76 Million; Revenue Falls to no Revenue

Reuters
·
Aug 05

Cyclerion Q1 net loss widens to $3.18 million; revenue turns to no revenue

Reuters
·
May 13

Top Premarket Decliners

MT Newswires Live
·
Apr 06

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences

Reuters
·
Apr 02

Top Midday Gainers

MT Newswires Live
·
Apr 02

Cyclerion Shares More Than Quadruple in Value to $7.10 on Merger Deal With Korsana

THOMSON REUTERS
·
Apr 01

Why is Cyclerion Therapeutics Stock (CYCN) Up Over 160% Today?

TIPRANKS
·
Apr 01

BUZZ-U.S. STOCKS ON THE MOVE-Seagate, nCino, Zymeworks

Reuters
·
Apr 01

BUZZ-Cyclerion rises on merger with Korsana Biosciences, $380 mln funding

Reuters
·
Apr 01

Cyclerion Therapeutics, Korsana Biosciences enter merger agreement

TIPRANKS
·
Apr 01

BRIEF-Cyclerion Therapeutics And Korsana Biosciences Announce Merger Agreement

Reuters
·
Apr 01

Cyclerion agrees all-stock merger with Korsana, to rename and trade as KRSA

Reuters
·
Apr 01

Cyclerion Therapeutics Inc - Korsana Secures Private Investment Commitments for $380 Mln Gross Proceeds

THOMSON REUTERS
·
Apr 01

Cyclerion Therapeutics Inc - Combined Company to Be Led by Jonathan Violin, Current CEO of Korsana

THOMSON REUTERS
·
Apr 01

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement

THOMSON REUTERS
·
Apr 01

Cyclerion Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
Mar 28

Top News Today/Canada: Government Records C$5.07 Billion Budget Deficit

Dow Jones
·
Mar 28

Cyclerion Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
Mar 24

Top News Today: Stocks Slide, Treasury Yields Rise Amid Oil Shock

Dow Jones
·
Mar 21

Top News Today/Canada: Retail Sales Rose 1.1% in January

Dow Jones
·
Mar 21